Comparison of gene expression patterns induced by treatment of human umbilical vein endothelial cells with IFN-α2b vs. IFN-β1a:: Understanding the functional relationship between distinct type I interferons that act through a common receptor

被引:55
作者
da Silva, AJ
Brickelmaier, M
Majeau, GR
Lukashin, AV
Peyman, J
Whitty, A
Hochman, PS
机构
[1] Biogen Inc, Cambridge, MA 02142 USA
[2] CuraGen Corp, New Haven, CT 06511 USA
关键词
D O I
10.1089/107999002753536149
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We analyzed whether interferon-alpha2b (IFN-alpha2b) and IFN-beta1a engage their common receptor to generate activated receptor complexes possessing distinct signaling properties. Human vascular endothelial cells (HUVEC) are 100-1000-fold more sensitive to IFN-beta1a than to IFN-alpha2b in in vitro assays. An nonarray-based expression profiling (GeneCalling) technology was employed to compare the patterns and levels of gene expression induced by these IFN as the broadest means by which signaling events could be measured. To distinguish subtype-related differences from dose-related effects, RNA was prepared from HUVEC treated with 50-5000 pg/ml of each IFN. The results showed that at 50 pg/ml IFN, only a subset of the genes induced by IFN-beta1a were also induced by IFN-alpha2b and that individual genes were induced to higher levels by IFN-beta1a. In contrast, at 5000 pg/ml, both subtypes induced essentially identical sets of genes to similar levels of expression. No genes were seen to be induced uniquely by IFN-alpha2b but not by IFN-beta1a. The results show that the two IFN are intrinsically capable of inducing similar gene induction responses and do not provide evidence that they generate activated receptor complexes possessing distinct signaling properties. In contrast, the two IFN generate gene induction patterns that are both qualitatively and quantitatively distinct at subsaturating and potentially physiologically more relevant concentrations.
引用
收藏
页码:173 / 188
页数:16
相关论文
共 72 条
[1]  
AART EHL, 1987, SIMULATED ANNEALING
[2]   DIFFERENTIAL TYROSINE PHOSPHORYLATION OF THE IFNAR CHAIN OF THE TYPE-I INTERFERON RECEPTOR AND OF AN ASSOCIATED SURFACE PROTEIN IN RESPONSE TO IFN-ALPHA AND IFN-BETA [J].
ABRAMOVICH, C ;
SHULMAN, LM ;
RATOVITSKI, E ;
HARROCH, S ;
TOVEY, M ;
EID, P ;
REVEL, M .
EMBO JOURNAL, 1994, 13 (24) :5871-5877
[3]   Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function [J].
Adachi, O ;
Kawai, T ;
Takeda, K ;
Matsumoto, M ;
Tsutsui, H ;
Sakagami, M ;
Nakanishi, K ;
Akira, S .
IMMUNITY, 1998, 9 (01) :143-150
[4]   Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays [J].
Alon, U ;
Barkai, N ;
Notterman, DA ;
Gish, K ;
Ybarra, S ;
Mack, D ;
Levine, AJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (12) :6745-6750
[5]   Characterization of a soluble ternary complex formed between human interferon-β-1a and its receptor chains [J].
Arduini, RM ;
Strauch, KL ;
Runkel, LA ;
Carlson, MM ;
Hronowski, XP ;
Foley, SF ;
Young, CN ;
Cheng, WJ ;
Hochman, PS ;
Baker, DP .
PROTEIN SCIENCE, 1999, 8 (09) :1867-1877
[7]   The cloning and characterization of human MyD88: A member of an IL-1 receptor related family [J].
Bonnert, TP ;
Garka, KE ;
Parnet, P ;
Sonoda, G ;
Testa, JR ;
Sims, JE .
FEBS LETTERS, 1997, 402 (01) :81-84
[8]   HUMAN INTERFERON REGULATORY FACTOR-I - INTRON EXON ORGANIZATION [J].
CHA, Y ;
SIMS, SH ;
ROMINE, MF ;
KAUFMANN, M ;
DEISSEROTH, AB .
DNA AND CELL BIOLOGY, 1992, 11 (08) :605-611
[9]   INTERFERON-INDUCED 56,000 MR PROTEIN AND ITS MESSENGER-RNA IN HUMAN-CELLS - MOLECULAR-CLONING AND PARTIAL SEQUENCE OF THE CDNA [J].
CHEBATH, J ;
MERLIN, G ;
METZ, R ;
BENECH, P ;
REVEL, M .
NUCLEIC ACIDS RESEARCH, 1983, 11 (05) :1213-1226
[10]   INTERFERON-INDUCED GUANYLATE-BINDING PROTEINS LACK AN N(T)KXD CONSENSUS MOTIF AND BIND GMP IN ADDITION TO GDP AND GTP [J].
CHENG, YSE ;
PATTERSON, CE ;
STAEHELI, P .
MOLECULAR AND CELLULAR BIOLOGY, 1991, 11 (09) :4717-4725